Ureaplasma urealyticum meningitis in an adult patient

Journal of Clinical Microbiology

Volumn 46, Issue 3, 2008, Pages 1141-1143

  Geißdörfer, Walter ^a   Sandner, Günter ^a   John, Stefan ^a   Gessner, André ^a   Schoerner, Christoph ^a   Schröppel, Klaus ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; DOXYCYCLINE; MEROPENEM; MOXIFLOXACIN; TOBRAMYCIN;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; LABORATORY TEST; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM;

ADULT; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; CHLORAMPHENICOL; DNA GYRASE; DNA TOPOISOMERASE IV; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MENINGITIS, BACTERIAL; MOLECULAR SEQUENCE DATA; QUINOLONES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

UREAPLASMA UREALYTICUM;

EID: 40749084840     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01628-07     Document Type: Article

References (13)

1. Balbi, H. J. 2004. Chloramphenicol: a review. Pediatr. Rev. 25:284-288.
2. Bébéar, C. M., H. Renaudin, A. Charron, M. Clerc, S. Pereyre, and C. Bébéar. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob. Agents Chemother. 47:3323-3325.
3. Bebear, C. M., H. Renaudin, A. Charron, D. Gruson, M. Lefrancois, and C. Bebear. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum ftuoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother. 44:2557-2560.
4. Chapin, K. C., and T.-L. Lauderdale. 2003. Reagents, stains, and media: bacteriology, p. 365-366. In P. M. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology. ASM Press, Washington, DC.
5. Kong, F., Z. Ma, G. James, S. Gordon, and G. L. Gilbert. 2000. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J. Clin. Microbiol. 38:1175-1179.
6. Matlow, A., C. Th'ng, D. Kovach, P. Quinn, M. Dunn, and E. Wang. 1998. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. Antimicrob. Agents Chemother. 42:1290-1292.
7. Ponticelli, C., and M. R. Campise. 2005. Neurological complications in kidney transplant recipients. J. Nephrol. 18:521-528.
8. Relman, D. A., T. M. Schmidt, R. P. MacDermott, and S. Falkow. 1992. Identification of the uncultured bacillus of Whipple's disease. N. Engl. J. Med. 327:293-301.
9. Robertson, J. A., G. W. Stemke, J. W. Davis, Jr., R. Harasawa, D. Thirkell, F. Kong, M. C. Shepard, and D. K. Ford. 2002. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int. J. Syst. Evol. Microbiol. 52:587-597.
10. Tunkel, A. R., B. J. Hartman, S. L. Kaplan, B. A. Kaufman, K. L. Roos, W. M. Scheid, and R. J. Whitley. 2004. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:1267-1284.
11. Waites, K. B., B. Katz, and R. L. Schelonka. 2005. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 18:757-789.
12. Xie, X., and J. Zhang. 2006. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol. Lett. 259:181-186.
13. Zhang, W., Y. Wu, W. Yin, and M. Yu. 2002. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites. Chin. Med. J. (Engl.) 115:1573-1575.